Key result
Homozygous GYG1 variant links to metabolic HCM, myocardial fibrosis, and Brugada phenocopy.
Why the study?
Predominant cardiac involvement in glycogen storage disease Type XV caused by GYG1 variants is exceptional and not well characterized.
Case Report (n=1)
This case expands the recognized phenotype of GYG1-related disease to include metabolic hypertrophic cardiomyopathy with a substrate-related Brugada phenocopy, suggesting a link between structural remodeling and arrhythmogenic electrical manifestations.
GYG1 variants may cause metabolic HCM with fibrosis and Brugada phenocopy; leaves open broader phenotypic spectrum pending larger studies.
Glycogen storage disease Type XV (GSD-XV; OMIM #613507) is an ultra-rare autosomal recessive disorder caused by biallelic pathogenic variants in GYG1, typically presenting with late-onset skeletal myopathy, while predominant cardiac involvement is exceptional. We report a 31-year-old man with chest pain, fatigue, and exertional dyspnea whose electrocardiogram demonstrated a spontaneous Type-1 Brugada pattern with complete right bundle branch block. Transthoracic echocardiography revealed nonobstructive left ventricular hypertrophy with preserved ejection fraction, whereas speckle-tracking showed markedly reduced global longitudinal strain with a heterogeneous distribution and absence of apical sparing. Cardiac magnetic resonance demonstrated mid-to-apical hypertrophy and patchy nonischemic late gadolinium enhancement consistent with myocardial fibrosis. Clinical exome sequencing identified a homozygous pathogenic GYG1 variant (NM_004130.4:c.304G>C; p.(Asp102His)) supported by functional evidence and familial segregation consistent with autosomal recessive inheritance. No pathogenic variants were detected in genes classically associated with Brugada syndrome, supporting a substrate-related Brugada phenocopy. Neurological examination, serum creatine kinase levels, and systemic evaluation were unremarkable. This case further expands the recognized cardiac phenotype associated with GYG1 deficiency by illustrating the coexistence of metabolic hypertrophic cardiomyopathy, myocardial fibrosis, and a Brugada phenocopy pattern, while highlighting a potential link between structural remodeling and arrhythmogenic electrical manifestations.
No takes yet. Share an insight, caveat, or question.
Arat et al. (2026) conducted a case report in GYG1-Related Disease (n=1). Homozygous pathogenic GYG1 variant was evaluated. A homozygous pathogenic GYG1 variant was identified in a 31-year-old man, expanding the cardiac phenotype to include metabolic hypertrophic cardiomyopathy, myocardial fibrosis, and a Brugada phenocopy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: